![Claudia Mitchell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Claudia Mitchell
Directeur/Membre du Conseil chez
GUBRA A/S
Fortune : 41 935 $ au 30/06/2026
Profil
Claudia Mitchell was the founder of Halo-Bio RNAi Therapeutics, Inc., founded in 2008, serving as Chief Scientific Officer from 2008 to 2011.
Dr. Mitchell is also the founder of Universal Cells, Inc...
Current jobs include Director at Gubra A starting in 2025, Director at Life Science Washington, Independent Non-Executive Director at Horama SA since 2022, and Board Member at Reaction Capital since 2019.
Former jobs include Independent Director at Adocia SA from 2021 to 2024, Director at French-American Chamber of Commerce, Director at Alliance for Regenerative Medicine, Member of board at Cci France International from 2017 to 2019, and Senior VP-Product & Portfolio Strategy at Astellas Pharma, Inc. Education includes an MBA from Ecole Des Ponts Business School and a doctorate from Universite Paris Cite.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GUBRA A/S 0,01 % | 31/12/2025 | 852 ( 0,01 % ) | 41 935 $ | 30/06/2026 |
Postes actifs de Claudia Mitchell
| Sociétés | Poste | Début |
|---|---|---|
| GUBRA A/S | Directeur/Membre du Conseil | 01/04/2025 |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Directeur/Membre du Conseil | - |
Reaction Capital
 Reaction Capital Investment ManagersFinance Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements. | Directeur/Membre du Conseil | 01/07/2019 |
Horama SA
 Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Directeur/Membre du Conseil | 20/10/2022 |
Anciens postes connus de Claudia Mitchell
| Sociétés | Poste | Fin |
|---|---|---|
| ADOCIA | Directeur/Membre du Conseil | 13/06/2024 |
Cci France International
 Cci France International Miscellaneous Commercial ServicesCommercial Services Operates as an independent association that brings together french and foreign companies | Directeur/Membre du Conseil | 01/02/2019 |
Halo-Bio RNAi Therapeutics, Inc.
 Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Develops multi-gene targeting products for the treatment of disease | Fondateur | 01/02/2011 |
French-American Chamber of Commerce
 French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Directeur/Membre du Conseil | - |
| ASTELLAS PHARMA INC. | Corporate Officer/Principal | - |
Formation de Claudia Mitchell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Universal Cells, Inc.
 Universal Cells, Inc. BiotechnologyHealth Technology Developing, licenses and commercializes stem cell therapies | Health Technology |
Astellas Pharma, Inc.
 Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Chamber of Commerce | Commercial Services |
Washington Biotechnology & Biomedical Association
Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Adocia SA
 Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Halo-Bio RNAi Therapeutics, Inc.
Halo-Bio RNAi Therapeutics, Inc. BiotechnologyHealth Technology Develops multi-gene targeting products for the treatment of disease | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Health Technology |
Cci France International
Cci France International Miscellaneous Commercial ServicesCommercial Services Operates as an independent association that brings together french and foreign companies | Commercial Services |
Gubra A/S
 Gubra A/S Miscellaneous Commercial ServicesCommercial Services Operates as a clinical contract research and drug discovery company | Commercial Services |
Ecole Des Ponts Business School
 Ecole Des Ponts Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universite Paris Cite
 Universite Paris Cite Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reaction Capital
Reaction Capital Investment ManagersFinance Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements. | Finance |
